Performance vs S&P 500

03
Tracked Q1 2025–Q2 2026 +135.7%
S&P 500 total return (same window) +37.0%
Excess return +98.7%

Annualized: +98.6% · S&P 500: +28.7%

Approximates a buy-and-hold portfolio built from quarterly SEC 13F snapshots. Excludes cash, short positions, options/derivatives, and non-13(f) securities — reflects the disclosed long-equity book only, not total fund AUM. SEC filing lag is up to 45 days; this is not a real-time-copyable timing.

Priceable coverage: 96.7% · Options excluded: 0.0%

Sector breakdown

04
Healthcare 100.0%

Full portfolio 14 positions

05
Type Streak 8Q trend
BBIO BridgeBio Pharma, Inc. - Common Stock $341,834,227 72.48% 4,589,611 $-36,120,286 Down ×1
GLUE Monte Rosa Therapeutics, Inc. - Common Stock $37,647,069 7.98% 1,555,664 $12,056,396
SNDX Syndax Pharmaceuticals, Inc. - Common Stock $28,785,379 6.10% 1,316,806 $-1,975,209
CMPS COMPASS Pathways Plc - American Depository Shares $20,267,554 4.30% 1,432,336 $12,346,736
BCAX Bicara Therapeutics Inc. - Common Stock $16,891,205 3.58% 568,919 $5,575,406
BBOT BridgeBio Oncology Therapeutics, Inc. - Common Stock $7,757,297 1.64% 1,018,018 $-1,353,964
SRRK Scholar Rock Holding Corporation - Common Stock $4,236,705 0.90% 77,031 $449,861
URGN UroGen Pharma Ltd. - Ordinary Shares $3,974,400 0.84% 108,000 $2,032,560
BMEA Biomea Fusion, Inc. - Common Stock $3,011,673 0.64% 2,048,757 $-122,925
ACRS Aclaris Therapeutics, Inc. - Common Stock $2,298,267 0.49% 434,455 $669,061
EPRX Eupraxia Pharmaceuticals Inc. - Common Stock $2,148,250 0.46% 325,000 $-204,750
VTVT vTv Therapeutics Inc. - Class A Common Stock $1,882,500 0.40% 50,000 Up ×1
MRKR Marker Therapeutics, Inc. - Common Stock $478,293 0.10% 325,370 $55,312
OKUR OnKure Therapeutics, Inc. - Class A Common Stock $404,048 0.09% 88,607 $37,215

Biggest new bets

09

New positions opened this quarter, largest first.

SecurityValueShares% of portfolio
VTVT $1,882,500 50,000 0.40%

Top movers (QoQ)

10
SecurityActionShares ΔValue Δ
BBIO Trimmed -500K -$36.1M
CMPS Price move only +0 +$12.3M
GLUE Price move only +0 +$12.1M
BCAX Price move only +0 +$5.6M
URGN Price move only +0 +$2.0M
SNDX Price move only +0 -$2.0M
BBOT Price move only +0 -$1.4M
ACRS Price move only +0 +$669K
SRRK Price move only +0 +$450K
EPRX Price move only +0 -$205K

Exited positions

11

Includes corporate events (mergers, delistings) — not all exits are sells

Closed positions reflect 13F reporting changes; for index managers these are often mechanical (delisting, M&A, index rebalancing), not active decisions.

SecurityQuarterShares beforeValue beforePrice since exit
VRNA Dec. 31, 2025 615,352 $65,664,212 No longer tracked
NUVB Dec. 31, 2025 2,960,659 $10,954,438 -45.5%
CALC March 31, 2026 521,114 $3,434,141 -44.8%
ELEV Sept. 30, 2025 2,834,910 $1,040,695 No longer tracked